Andrew E. Place, MD, PhD¹, Seth E. Karol, MD², Christopher J. Forlenza, MD^3*, Marion Gambart, MD^4*, Todd M. Cooper, DO⁵, Christopher Fraser, MBBS^6*, Gunnar Cario, MD, PhD^7*, Maureen M O'Brien, MD⁸, Nicolas U. Gerber, MD^9*, Phillip Barnette, MD^10*, Dirk Reinhardt, MD PhD¹¹, Giridharan Ramsingh, MD^12*, Bo Tong, PhD^13*, Kristina Unnebrink, PhD^14*, Deeksha Vishwamitra, PhD^13*, Fengjiao Dunbar, PhD^13*, Betty A. Prine, BS^13*, Tammy L. Palenski, PhD¹³ and Mignon L. Loh, MD¹⁵

¹Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA
²Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴CHU de Toulouse, Toulouse, France
⁵Seattle Children’s Hospital, Cancer and Blood Disorders Center, Seattle, WA
⁶Queensland Children's Hospital, South Brisbane, QLD, Australia
⁷Universitätsklinikum Schleswig-Holstein, Kiel, Germany
⁸Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH
⁹University Children's Hospital Zurich, Zurich, Switzerland
¹⁰Primary Children's Hospital, Salt Lake City, UT
¹¹University of Duisburg-Essen, Essen, Germany
¹²Genentech, Inc., South San Francisco, CA
¹³AbbVie Inc., North Chicago, IL
¹⁴AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany
¹⁵UCSF Benioff Children’s Hospital and the Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA

Sumit Gupta, MD¹, David T. Teachey, MD², Meenakshi Devidas, PhD^3*, Zhiguo Chen^4*, Kimberly P. Dunsmore, MD^5*, Eric C Larsen, MD^6*, Kelly Maloney, MD⁷, Leonard A. Mattano, MD⁸, Stuart S. Winter, MD⁹, Andrew J Carroll^10*, Nyla A Heerema, PhD^11*, Michael J Borowitz, MD, PhD¹², Brent L Wood, MD, PhD¹³, William L. Carroll, MD¹⁴, Naomi J Winick, MD¹⁵, Elizabeth A. Raetz, MD¹⁶, Mignon L. Loh, MD¹⁷ and Stephen P. Hunger, MD¹⁸

¹Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada
²Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and The Perelman School of Medicine at The University of Pennsylvania, Rutledge, PA
³Department of Global Pediatric Medicine, St. Jude Children’s Research Hospital, Memphis, TN
⁴Department of Biostatistics, Colleges of Medicine, Public Health, and Health Professions, University of Florida, Gainesville, FL
⁵Department of Pediatrics, Virginia Tech Carilion School of Medicine, Roanoke, VA
⁶Department of Pediatrics, Maine Children's Cancer Program, Scarborough, ME
⁷Children’s Hospital Colorado and the Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO
⁸HARP Pharma Consulting, Mystic, CT
⁹University of New Mexico Health Cancer Center, Albuquerque, NM
¹⁰Department of Genetics, University of Alabama, Birmingham, AL
¹¹Department of Pathology, Ohio State University, Wexner School of Medicine, Columbus, OH
¹²Johns Hopkins Hospital, Baltimore, MD
¹³Department of Laboratory Medicine, University of Washington, Seattle, WA
¹⁴NYU Langone Medical Center, New York, NY
¹⁵Department of Pediatrics, Division of Pediatric Hematology/Oncology, UT Southwestern, Simmons Cancer Center, and Perlmutter Cancer Center, Dallas, TX
¹⁶New York University Langone Medical Center, New York, NY
¹⁷Benioff Children's Hospital and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
¹⁸Department of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA

Nicola Goekbuget, MD¹, Wiba Keke Wermann^2*, Stefan Schwartz, MD, PhD^3*, Andreas Hüttmann, MD⁴, Christoph Faul, MD⁵, Simon Raffel, MD^6*, Andreas Viardot, Professor Dr⁷, Walter Fiedler, MD⁸, Nael Alakel, MD^9*, Matthias Stelljes, MD¹⁰, Marion Subklewe, MD¹¹, Ralph Wäsch¹², Sonja Martin, MD^13*, Wolfram Jung, MD^14*, Vladan Vucinic, MD^15*, Mustafa Kondakci, MD^16*, Lars R. Fransecky, MD^17*, Daniela Heidenreich, MD^18*, Knut Wendelin, MD^19*, Julian Hermann^2*, Hubert Serve, MD, PhD², Ralf C Bargou, MD, PhD^20*, Max S. Topp, MD²¹ and Monika Brüggemann, MD^22*

¹University Hospital, Department of Medicine II, Hematology/Oncology, Head of Study Center Depart of Medicine II, Hematology/Oncology Goethe University Hospital, Frankfurt, Germany
²University Hospital, Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt, Germany
³Department of Hematology / Oncology, Charité - Universitätsmedizin Berlin, Berlin, Germany
⁴Department of Hematology, University Hospital, Essen, NRW, Germany
⁵University Hospital Tübingen, Tübingen, Germany
⁶Department of Medicine V, University of Heidelberg, Heidelberg, Germany
⁷Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
⁸Department of Oncology, Hematology and Bone Marrow Transplantation With Section Pneumology, Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
⁹University Hospital, Dresden, Germany
¹⁰Deptartment of Medicine A, University of Muenster, Muenster, Germany
¹¹Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
¹²Department of Hematology and Oncology, University of Freiburg Medical Center, Freiburg, Germany
¹³Department of Hematology and Oncology, Robert-Bosch-Hospital, Stuttgart, Germany
¹⁴Dept. of Hematology and Oncology, Universitätsklinikum Göttingen, Göttingen, Germany
¹⁵Department of Hematology and Oncology, University of Leipzig, Leipzig, Germany
¹⁶Dept. of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
¹⁷University Hospital Schleswig-Holstein, Kiel, Germany
¹⁸UMM University Medical Center Mannheim, University of Heidelberg, Mannheim, DEU
¹⁹Klinikum Nuernberg Nord, Nuernberg, Germany
²⁰Comprehensive Cancer Center Mainfranken, Universitätsklinikum Würzburg, Würzburg, Germany
²¹Medizinische Klinik Und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany
²²Medical Department II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany

Anand Ashwin Patel, MD¹, Joseph Heng, MD¹, Emily Dworkin, PharmD^1*, Sarah Monick, MD^2*, Benjamin A Derman, MD³, Sandeep Gurbuxani, MBBS, PhD⁴, Satyajit Kosuri, MD^5*, Hongtao Liu, MD, PhD¹, Michael Thirman, MD¹, Lucy A. Godley, MD, PhD⁶, Olatoyosi Odenike, MD¹, Richard A. Larson, MD⁵ and Wendy Stock, MD¹

¹Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL
²Department of Medicine, University of Chicago, Chicago, IL
³University of Chicago, Chicago, IL
⁴Department of Pathology, University of Chicago, Chicago, IL
⁵Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
⁶Department of Medicine, Univ. of Chicago Med. Ctr., Chicago, IL

Jonathan Webster, MD¹, Hua-Ling Tsai, ScM^2*, Eric Gehrie^3*, Tania Jain, MD⁴, Christopher S. Hourigan, MD, DPhil⁵, William Brian Dalton, MD, PhD⁶, Gabrielle T. Prince, MD^6*, Lukasz P. Gondek, MD, PhD⁷, Gabriel Ghiaur, MD, PhD⁸, Amy E. DeZern, MD¹, Margaret M. Showel, MD^4*, Ivana Gojo, MD¹, Douglas E Gladstone, MD¹, Philip H. Imus, MD¹, Javier Bolanos-Meade, MD⁹, Leo Luznik, MD¹⁰, Ephraim J. Fuchs, MD, MBA¹, Christian B. Gocke, MD, PhD¹¹, Abbas Abbas Ali, MD⁸, Carol Ann Huff, MD¹, Ivan M. Borrello, MD¹, Lode J. Swinnen, MB ChB¹², Nina D. Wagner-Johnston¹³, Richard F. Ambinder, MD¹⁴, Richard J. Jones, MD¹, B. Douglas Smith, MD¹⁵ and Mark Levis, MD, PhD¹

¹Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
²Oncology Biostatistics and Bioinformatics, Johns Hopkins University, Baltimore, MD
³Johns Hopkins University, Baltimore, MD
⁴Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
⁵Laboratory of Myeloid Malignancies, Hematology Branch, NHLBI, Bethesda, MD
⁶Johns Hopkins Hospital, Baltimore, MD
⁷Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD
⁸Sidney Kimmel Comprehensive Cancer Center, John's Hopkins Hospital, Baltimore, MD
⁹Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University Kimmel Cancer Center, Ellicott City, MD
¹⁰Sidney Kimmel Comprehensive Cancer Ctr., Baltimore, MD
¹¹Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins/Sidney Kimmel Cancer Center, Baltimore, MD
¹²Division of Medical Oncology, Johns Hopkins Cancer Center, Baltimore, MD
¹³Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD
¹⁴Sidney Kimmel Cancer Center at Johns Hopkins, Baltimore, MD
¹⁵Johns Hopkins Medical Institutes, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD

Elad Jacoby, MD^1,2, Sara Ghorashian, FRCPath, PhD³, Britta Julia Vormoor, MD^4*, Barbara De Moerloose, MD^5*, Nicole Bodmer^6*, Michael Maschan, MD^7*, Asaf David Yanir, MD^8*, Bella Bielorai, MD^9*, Srdan Rogosic^10*, Olga Molostova, MD^7*, Claudia Rossig¹¹, Amos Toren, MD, PhD¹², Arend von Stackelberg, MD¹³ and Jean-Pierre Bourquin, MD, PhD¹⁴

¹The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, Israel
²Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
³Developmental Biology and Cancer, UCL Great Ormond Street Institute of Child Health, London, ENG, United Kingdom
⁴Princess Maxima Center for Paediatric Oncology, Utrecht, Netherlands
⁵Dept of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium
⁶University Children's Hospital Zürich, Zürich, Switzerland
⁷Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation
⁸Schneider Children's Medical Center, Petah Tikvah, Israel
⁹Division of Pediatric Hematology and Oncology, Sheba Medical Center, Ramat-Gan, Israel
¹⁰UCL Great Ormond Street Institute of Child Health, London, United Kingdom
¹¹Pediatric Hematology and Oncology, University Children's Hospital Muenster, Münster, Germany
¹²The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel
¹³Department of Pediatric Oncology/Hematology, Charite Medical Center, Berlin, Germany
¹⁴Universitaets-Kinderspital Zurich, Zurich, Switzerland

Frank Hoke^1*, Kara Schmelzer^2*, Jianping Zhang^2*, Philip Lorenzi, PhD³ and Iman El-Hariry, MD, PhD^4*

¹Clinical Pharmacology, Erytech Pharma, Cambridge, MA
²Quantitative Clinical Development, Parexel International, Durham, NC
³Bioinformatics & Comp Biology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Erytech Pharma, LYON, FRA

Rosana Daniela Córdova-Serrano, MD^1*, Emmanuel Almanza Huante, MD, MDN², Emmanuel Mártinez-Moreno, MD^1*, Areli Hérnandez-Alcántara, MD^3*, Emmanuel Fernández-Sánchez, MD^4*, Andres Gomez-De Leon, MD⁵ and Karla Adriana Espinosa, MD^6*

¹Hematology, Instituto Nacional de Cancerologia México, Mexico City, Mexico
²Grupo de trabajo de leucemias agudas, Mexico City, Mexico
³Cytogenetics, Instituto Nacional de Cancerologia México, Mexico City, Mexico
⁴Transfusional Medicine, Instituto Nacional de Cancerologia México, Mexico City, Mexico
⁵Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr. José Eleuterio Gonzalez", Servicio de Hematología, Monterrey, Mexico
⁶Instituto Nacional de Cancerología, Mexico City, Mexico

Veronica A Guerra, MD¹, Yasmin Alwash, MD², Yan Yuanqing, PhD^3*, Jorge M. Ramos Perez, MD^4*, Guillaume Richard-Carpentier, MD², Ahmad S. Alotaibi, MD^5*, Hycienth O Ahaneku, MD, MPH, PhD⁴, Bachar Samra, MD^4*, Arrvind Raghunath, MD^4*, Nitin Jain, MD⁶, Nicholas J. Short, MD⁴, Farhad Ravandi, MBBS⁴, Gautam Borthakur, MD⁴, Alessandra Ferrajoli, MD⁴, Koji Sasaki, MD², Steven M. Kornblau, MD⁴, Zeev E. Estrov, MD⁴, Jorge E. Cortes, MD⁷, Hagop M. Kantarjian, MD⁴, Guillermo Garcia-Manero, MD⁴, Elias Jabbour, MD⁴ and Tapan M. Kadia, MD⁴

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Miami, FL
²Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
³University of Texas Health Science Center, Department of Neurosurgery, Houston
⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, TX
⁶The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Georgia Cancer Center Augusta University, Augusta, GA

Ksenya Shliakhtsitsava, MD, MAS¹, Jillian Grapsy, PharmD^2*, Christina Hsu, PharmD, BCPS^2*, Mohammad Almatrafi, MD^3*, Michael Sebert, MD^3*, Martha Pacheco, MD^1*, Rong Huang, MS^4* and Paul Sue, MD^3*

¹Department of Pediatrics, Pediatric Hematology-Oncology, University of Texas Southwestern Medical Center, Dallas, TX
²Department of Pharmacy, Children's Medical Center, Dallas, TX
³Department of Pediatrics, Pediatric Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, TX
⁴Research Department, Children's Health System of Texas, Children's Medical Center, Dallas, TX

Luis Felipe Rubalcava-Lara, MD^1*, Emmanuel Almanza Huante, MD, MDN², Roberta Demichelis, MD³, Juan Rangel-Patiño, MD³, Andres Gomez-De Leon, MD⁴, Gerardo A De la rosa-Flores, MD^5*, Alvaro Cabrera Garcia^6*, katheryn Betsabe Garzon, MD^7* and Karla Adriana Espinosa, MD^8*

¹Hematology, Instituto Nacional de Cancerologia México, Mexico City, DF, Mexico
²Grupo de trabajo de leucemias agudas, Mexico City, Mexico
³Department of Hematology and Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
⁴Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr. José Eleuterio Gonzalez", Servicio de Hematología, Monterrey, Mexico
⁵Hospital Universitario “Dr. José E. González”, Monterrey, Mexico
⁶Hospital de Alta Especialidad de Ixtapaluca, Ixtapaluca, MEX
⁷Instituto Nacional de Cancerología México, Mexico, MEX
⁸Instituto Nacional de Cancerología, Mexico City, Mexico